BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 25801062)

  • 1. Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria.
    Dosler S; Karaaslan E; Alev Gerceker A
    J Chemother; 2016 Apr; 28(2):95-103. PubMed ID: 25801062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.
    Dosler S; Karaaslan E
    Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melittin and its potential in the destruction and inhibition of the biofilm formation by Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa isolated from bovine milk.
    Picoli T; Peter CM; Zani JL; Waller SB; Lopes MG; Boesche KN; Vargas GDÁ; Hübner SO; Fischer G
    Microb Pathog; 2017 Nov; 112():57-62. PubMed ID: 28943153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.
    Bardbari AM; Arabestani MR; Karami M; Keramat F; Aghazadeh H; Alikhani MY; Bagheri KP
    Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):443-454. PubMed ID: 29353377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria.
    Simonetti O; Cirioni O; Ghiselli R; Orlando F; Silvestri C; Mazzocato S; Kamysz W; Kamysz E; Provinciali M; Giacometti A; Guerrieri M; Offidani A
    Peptides; 2014 May; 55():17-22. PubMed ID: 24531033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms.
    Dosler S; Mataraci E
    Peptides; 2013 Nov; 49():53-8. PubMed ID: 23988790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
    Akbari R; Hakemi-Vala M; Pashaie F; Bevalian P; Hashemi A; Pooshang Bagheri K
    Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt.
    Mohamed NM; Youssef AA
    Microb Drug Resist; 2011 Dec; 17(4):489-95. PubMed ID: 21875338
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Tan JH; Vidaillac C; Yam JKH; Chua SL; Givskov M; Yang L
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility to various antibiotics of colistin-resistant gram-negative bacterial isolates in a general tertiary hospital in Crete, Greece.
    Samonis G; Matthaiou DK; Kofteridis D; Maraki S; Falagas ME
    Clin Infect Dis; 2010 Jun; 50(12):1689-91. PubMed ID: 20482269
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins.
    Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
    Lora-Tamayo J; Murillo O; Bergen PJ; Nation RL; Poudyal A; Luo X; Yu HY; Ariza J; Li J
    J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection.
    Hengzhuang W; Wu H; Ciofu O; Song Z; Høiby N
    Antimicrob Agents Chemother; 2012 May; 56(5):2683-90. PubMed ID: 22354300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms.
    Novais JS; Moreira CS; Silva ACJA; Loureiro RS; Sá Figueiredo AM; Ferreira VF; Castro HC; da Rocha DR
    Microb Pathog; 2018 May; 118():105-114. PubMed ID: 29550501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents.
    Gradelski E; Kolek B; Bonner DP; Valera L; Minassian B; Fung-Tomc J
    Int J Antimicrob Agents; 2001 Feb; 17(2):103-7. PubMed ID: 11165113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological synergism of bee venom and melittin with antibiotics and plant secondary metabolites against multi-drug resistant microbial pathogens.
    Al-Ani I; Zimmermann S; Reichling J; Wink M
    Phytomedicine; 2015 Feb; 22(2):245-55. PubMed ID: 25765829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.